Metabolic & Endocrine Disease Summit (MEDS)
Minimally Invasive Surgery Symposium (MISS)
Cardiovascular and Respiratory Disease Summit (CARPS)
SDEF's 15th Annual Women's & Pediatric Dermatology
15th Annual Coastal Dermatology Symposium
SDEF's 20th Annual Las Vegas Dermatology Seminar & the 16th Annual SDEF Psoriasis Forum
Inaugural Cutaneous Malignancies Forum
19th Annual Caribbean Dermatology Symposium
SDEF's 44th Annual Hawaii Dermatology Seminar
6th Annual Digestive Diseases: New Advances Conference
Original Emergency Medicine Boot Camp
Pain Care for Primary Care
National Family Medicine Board Review
12th Annual Perspectives in Rheumatic Diseases
Pelvic Anatomy & Gynecologic Surgery Symposium (PAGS)
Acute Leukemia Forum 2019
CP/AACP Psychiatry Update
CP/AACP Focus on Neuropsychiatry
CP/AACP Current Psychiatry Update Encore
1.25 AMA PRA Category 1 Credit(s)™
1.0 AMA PRA Category 1 Credit™
0.25 AMA PRA Category 1 Credit(s)™
0.25 AMA PRA Category 1 Credit™
The retrospective analysis identifies previously unknown risk factor for skin cancer associated with allogeneic hematopoietic cell transplantation.
Shorter chemotherapy cycles and sequential dosing were associated with lower recurrence rates and better breast cancer-specific survival.
The ongoing study tracks with previous work showing no risk from dietary soy.
The findings highlight the need to screen high-risk subgroups of cancer survivors.
Staying up to date on screening was associated with a 62% decrease in the odds of dying from colorectal cancer.
Patients with sporadic clear cell renal cell carcinomas expressing PD-L1 had worse disease-free survival.
PHILADELPHIA – “We are on the cusp where new compounds not only are being tested, but they are being approved.”
There are no results under this Specialty.